We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00100776
Recruitment Status : Completed
First Posted : January 7, 2005
Last Update Posted : January 26, 2007
Sponsor:
Information provided by: